Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Worsley C, Bianco M, Noble-Longster J, Prentice E, Prowse A, Cooper C, Strickson A. A systematic review of clinical efficacy and safety data in penta-refractory multiple myeloma: findings indicate the challenges for HTA submission. Poster HTA236. Presented at: ISPOR Europe 2023; 12-15 November 2023; Copenhagen, Denmark.